ATAI vs. IOVA
Compare and contrast key facts about Atai Life Sciences N.V. (ATAI) and Iovance Biotherapeutics, Inc. (IOVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ATAI or IOVA.
Key characteristics
| ATAI | IOVA | |
|---|---|---|
| YTD Return | 11.35% | 9.23% |
| 1Y Return | -8.72% | 1.72% |
| Sharpe Ratio | -0.14 | 0.02 |
| Daily Std Dev | 87.61% | 93.77% |
| Max Drawdown | -94.77% | -99.36% |
| Current Drawdown | -92.11% | -94.42% |
Fundamentals
| ATAI | IOVA | |
|---|---|---|
| Market Cap | $277.89M | $2.58B |
| EPS | -$0.22 | -$1.75 |
| Revenue (TTM) | $314.00K | $1.90M |
| Gross Profit (TTM) | $233.00K | $0.00 |
| EBITDA (TTM) | -$121.95M | -$451.03M |
Correlation
The correlation between ATAI and IOVA is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ATAI vs. IOVA - Performance Comparison
In the year-to-date period, ATAI achieves a 11.35% return, which is significantly higher than IOVA's 9.23% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ATAI vs. IOVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ATAI vs. IOVA - Dividend Comparison
Neither ATAI nor IOVA has paid dividends to shareholders.
Drawdowns
ATAI vs. IOVA - Drawdown Comparison
The maximum ATAI drawdown since its inception was -94.77%, roughly equal to the maximum IOVA drawdown of -99.36%. Use the drawdown chart below to compare losses from any high point for ATAI and IOVA. For additional features, visit the drawdowns tool.
Volatility
ATAI vs. IOVA - Volatility Comparison
The current volatility for Atai Life Sciences N.V. (ATAI) is 20.54%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 22.58%. This indicates that ATAI experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ATAI vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities